Safiye Celik

Safiye Celik

Auto-generated profile, based on publicly available information

Safiye Celik

Recursion

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2024 in PLOS Computational Biology
Verified
Journal Article
Open access
PDF file
SCSafiye Celik
Safiye Celik
JHJan-Christian Hütter
Jan-Christian Hütter
SCSandra Melo Carlos
Sandra Melo Carlos
NLNathan H Lazar
Nathan H Lazar
RMRahul Mohan
Rahul Mohan
IHImran S Haque
Imran S Haque
The continued scaling of genetic perturbation technologies combined with high-dimensional assays such as cellular microscopy and RNA-sequencing has enabled genome-scale reverse-genetics experiments that go beyond single-endpoint measurements of growth or lethality. Datasets emerging from these experiments can be combined to construct perturbative “maps of biology”, in which readouts from various manipulations (e.g., CRISPR-Cas9 knockout, CRISPRi knockdown, compound treatment) are placed in unified, relatable embedding spaces allowing for the generation of genome-scale sets of pairwise comparisons. These maps of biology capture known biological relationships and uncover new associations which can be used for downstream discovery tasks. Construction of these maps involves many technical choices in both experimental and computational protocols, motivating the design of benchmark procedures to evaluate map quality in a systematic, unbiased manner. Here, we (1) establish a standardized terminology for the steps involved in perturbative map building, (2) introduce key classes of benchmarks to assess the quality of such maps, (3) construct 18 maps from four genome-scale datasets employing different cell types, perturbation technologies, and data readout modalities, (4) generate benchmark metrics for the constructed maps and investigate the reasons for performance variations, and (5) demonstrate utility of these maps to discover new biology by suggesting roles for two largely uncharacterized genes.

17 December 2024 in Nature Biomedical Engineering
Verified
Journal Article
Closed access
PDF file
WQWei Qiu
Wei Qiu
ADAyse B. Dincer
Ayse B. Dincer
JJJoseph D. Janizek
Joseph D. Janizek
SCSafiye Celik
Safiye Celik
MPMikael J. Pittet
Mikael J. Pittet
SLSu-In Lee
Su-In Lee

12 December 2022 in bioRxiv
Verified
Preprint
Open access
PDF file
SCSafiye Celik
Safiye Celik
JHJan-Christian Hütter
Jan-Christian Hütter
SCSandra Melo Carlos
Sandra Melo Carlos
NLNathan H Lazar
Nathan H Lazar
RMRahul Mohan
Rahul Mohan
IHImran S Haque
Imran S Haque
1 The continued scaling of genetic perturbation technologies combined with high-dimensional assays such as cellular microscopy and RNA-sequencing has enabled genome-scale reverse-genetics experiments that go beyond single-endpoint measurements of growth or lethality. Datasets emerging from these experiments can be combined to construct perturbative “maps of biology”, in which readouts from various manipulations (e.g., CRISPR-Cas9 knockout, CRISPRi knockdown, compound treatment) are placed in unified, relatable embedding spaces allowing for the generation of genome-scale sets of pairwise comparisons. These maps of biology capture known biological relationships and uncover new associations which can be used for downstream discovery tasks. Construction of these maps involves many technical choices in both experimental and computational protocols, motivating the design of benchmark procedures to evaluate map quality in a systematic, unbiased manner. Here, we (1) establish a standardized terminology for the steps involved in perturbative map building, (2) introduce key classes of benchmarks to assess the quality of such maps, (3) construct maps from four genome-scale datasets employing different cell types, perturbation technologies, and data readout modalities, (4) generate benchmark metrics for the constructed maps and investigate the reasons for performance variations, and (5) demonstrate utility of these maps to discover new biology by suggesting roles for two largely uncharacterized genes. 2 Author Summary: With the proliferation of genetic perturbation, laboratory robotics, computer vision and sequencing technologies, a growing number of researchers are producing datasets that capture digital readouts of cellular responses to genetic perturbations at the full-genome-scale. Since each of these efforts utilizes different cellular models, experimental approaches, terminology, code bases, analysis methods and quality metrics, it is exceptionally difficult to reason through the pros and cons of possible design choices or even discuss the primary considerations when embarking on such an endeavor. These datasets can be powerful discovery tools to look at known biological relationships and uncover new associations in an unbiased manner, but only when paired with a computational pipeline to assemble the data into a digestible format. Moreover, there is great promise in looking across these data to highlight commonalities and differences that may be attributed to experimental or analytical approaches or the biological context. Therefore, a unified framework is necessary to align this nascent field and speed progress in assessing technologies and methods. In this work we define a unified framework for building and benchmarking these perturbative maps, benchmark four different datasets assembled into 18 different maps, explore the impact of different design decisions and demonstrate how these maps can be used to elucidate gene functions. The framework we propose highlights the necessary steps for building any such map - embedding, filtering, aligning, aggregating and relating the data across perturbations. For benchmarking, we propose two main types of metrics and give examples which highlight the impact of different processing pipelines. Finally, we explore these maps to demonstrate their utility for confirming known biological relationships and nominating annotations for genes with unknown function. We expect that this work will positively impact the nascent field of perturbative map building by enabling easier comparisons within and between technologies and methods through a shared language. Additionally, the associated code base is openly available and flexible enough to be easily extended with new methods, so we hope that it will become a resource for future researchers working on developing both laboratory and computational methodology. While there are too many confounding variables to make recommendations on the strengths of different technologies and cellular models at this time, highlighting that fact may prompt studies designed with the goal of directly comparing methods while holding other confounding variables fixed. Moreover, as the number of perturbative maps grows, the field will naturally consider the advantages of combining maps across modalities and the framework provided here can also help guide the evaluation of those efforts.

15 April 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
NLNathan H. Lazar
Nathan H. Lazar
SCSafiye Celik
Safiye Celik
LCLu Chen
Lu Chen
MFMarta Fay
Marta Fay
JIJonathan C. Irish
Jonathan C. Irish
IHImran S. Haque
Imran S. Haque
Summary: CRISPR-Cas9 editing is a scalable technology for mapping of biological pathways, but it has been reported to cause a variety of undesired large-scale structural changes to the genome. We performed an arrayed CRISPR-Cas9 scan of the genome in primary human cells, targeting 17,065 genes for knockout with 101,029 guides. High-dimensional phenomics reveals a “proximity bias” in which CRISPR knockouts bear unexpected phenotypic similarity to knockouts of biologically-unrelated genes on the same chromosome arm, recapitulating both canonical genome structure and structural variants. Transcriptomics connects proximity bias to chromosome-arm truncations. Analysis of published large-scale knockout and knockdown experiments confirms that this effect is general across cell types, labs, Cas9 delivery mechanisms, and assay modalities, and suggests proximity bias is caused by DNA double-strand-breaks with cell cycle control in a mediating role. Finally, we demonstrate a simple correction for large-scale CRISPR screens to mitigate this pervasive bias while preserving biological relationships.

27 May 2018 in bioRxiv
Verified
Preprint
Open access
PDF file
NBNicasia Beebe-Wang
Nicasia Beebe-Wang
SCSafiye Celik
Safiye Celik
SLSu-In Lee
Su-In Lee
Systematic modeling of Alzheimer’s Disease (AD) neuropathology based on brain gene expression would provide valuable insights into the disease. However, relative scarcity and regional heterogeneity of brain gene expression and neuropathology datasets obscure the ability to robustly identify expression markers. We propose MD-AD (Multi-task Deep learning for AD) to effectively combine heterogeneous AD datasets by simultaneously modeling multiple phenotypes with shared layers. MD-AD leads to an 8% and 5% reduction in mean squared error over MLP for predicting counts of two AD hallmarks: plaques and tangles. It also leads to a 40% and 30% reduction in classification error over MLP for two common staging systems for AD: CERAD score and Braak stage. Additionally, MD-AD’s network representation tends to better capture known metabolic pathways, including some AD-related pathways. Together, these results indicate that MD-AD is particularly useful for learning expressive network representations from heterogeneous and sparsely labeled AD data.

1 December 2020 in bioRxiv
Verified
Preprint
Open access
PDF file
NBNicasia Beebe-Wang
Nicasia Beebe-Wang
SCSafiye Celik
Safiye Celik
EWEthan Weinberger
Ethan Weinberger
PSPascal Sturmfels
Pascal Sturmfels
PJPhilip L. De Jager
Philip L. De Jager
SLSu-In Lee
Su-In Lee
Deep neural networks offer a promising approach for capturing complex, non-linear relationships among variables. Because they require immense sample sizes, their potential has yet to be fully tapped for understanding complex relationships between gene expression and human phenotypes. Encouragingly, a growing number of diseases are being studied through consortium efforts. Here we introduce a new analysis framework, namely MD-AD ( M ulti-task D eep learning for A lzheimer’s D isease neuropathology), which leverages an unexpected synergy between deep neural networks and multi-cohort settings. In these settings, true joint analysis can be stymied using conventional statistical methods, which (1) require “harmonized” phenotypes (i.e., measured in a highly consistent manner) and (2) tend to capture cohort-level variations, obscuring the subtler true disease signals. Instead, MD-AD incorporates multiple related phenotypes sparsely measured across cohorts, and learns complex, non-linear interactions between genes and phenotypes not discovered using conventional expression data analysis methods (e.g., component analysis and module detection), enabling the model to capture subtler signals than cohort-level variations. Applied to the largest available collection of brain samples (N=1,758), we demonstrate that MD-AD learns a truly generalizable relationship between gene expression program and AD-related neuropathology. The learned program generalizes in several important ways, including recapitulation of the disease progress in animal models and across tissue types, and we show that such generalizability is not achieved by previous statistical paradigms. Its ability to identify genes with high non-linear relevance to neuropathology enabled us to identify a sex-specific relationship between neuropathology and immune response across microglia, providing a nuanced context for association between inflammatory genes and AD.